| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000036782 |
| Receipt No. | R000041850 |
| Scientific Title | Analysis of airway and systemic effects of Heated tobacco products |
| Date of disclosure of the study information | 2019/05/18 |
| Last modified on | 2021/09/11 (Ver. 7) |
| Basic information | ||
| Public title | Analysis of airway and systemic effects of Heated tobacco products | |
| Acronym | Analysis of airway and systemic effects of Heated tobacco products | |
| Scientific Title | Analysis of airway and systemic effects of Heated tobacco products | |
| Scientific Title:Acronym | Analysis of airway and systemic effects of Heated tobscco products | |
| Region |
|
|
| Condition | ||
| Condition | Healthy subjects | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the airway effects of heated tobacco products |
| Basic objectives2 | Others |
| Basic objectives -Others | To investigate the airway effects of heated tobacco products |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | airway and systemic inflammatory response |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | more than 1 pack/day with(1)heated tobacco products and (2)cigarette smoke, or (3)non-smokers | |||
| Key exclusion criteria | lung diseases and chronic systemic diseases | |||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kawasaki Medical School | ||||||
| Division name | Respiratory Medicine | ||||||
| Zip code | 701-0162 | ||||||
| Address | 577 matsushima, Kurashiki city | ||||||
| TEL | 086-462-1111 | ||||||
| shonosuke@med.kawasaki-m.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kawasaki Medical School | ||||||
| Division name | Respiratory Medicine | ||||||
| Zip code | 701-0162 | ||||||
| Address | 577 matsushima, Kurashiki city | ||||||
| TEL | 086-462-1111 | ||||||
| Homepage URL | |||||||
| shonosuke@med.kawasaki-m.ac.jp | |||||||
| Sponsor | |
| Institute | Kawasaki Medical School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kawasaki Medical School ethics committee |
| Address | 577 matsushima, Kurashiki city |
| Tel | 086-464-1076 |
| kmsrec@med.kawasaki-m.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | If the subject is consented by a healthy volunteer, the subject will perform induction sputum, urine, blood, lung function test and exhaled breath NO test. The recruitment period is when 60 cases of the planned number of cases are gathered. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041850 |